Rivaroxaban/warfarinRetroperitoneal bleeding, major bleeding and epistaxis: 3 case reports

被引：0

|

作者：

机构：

来源：

Reactions Weekly | 2021年 / 1858卷 / 1期

关键词：

D O I：

10.1007/s40278-021-97064-y

中图分类号：

学科分类号：

摘要：

引用

收藏

页码：346 / 346

相关论文

共 50 条

[21] Nadroparin calcium/rivaroxaban/warfarinEpistaxis, haemoptysis and rectal bleeding: 3 case reports
Reactions Weekly, 2021, 1857 (1) : 261 - 261
[22] Dabigatran etexilateGI bleeding, haematuria and epistaxis: 4 case reports
Reactions Weekly, 2015, 1552 (1) : 82 - 82
[23] Rivaroxaban/warfarinSevere bleeding and pericardial effusion: 2 case reports
Reactions Weekly, 2015, 1569 (1) : 187 - 187
[24] Dabigatran/rivaroxabanGastrointestinal bleeding and bleeding: 3 case reports
Reactions Weekly, 2022, 1929 (1) : 224 - 224
[25] Apixaban/dabigatran etexilate/rivaroxabanHaematoma, epistaxis and bleeding: 5 case reports
Reactions Weekly, 2017, 1633 (1) : 81 - 81
[26] Dabigatran etexilate/rivaroxabanUterine major bleeding and gastrointestinal bleeding: 2 case reports
Reactions Weekly, 2018, 1695 (1) : 134 - 134
[27] Apixaban/rivaroxabanLack of efficacy and non major bleeding: 3 case reports
Reactions Weekly, 2022, 1889 (1) : 59 - 59
[28] HeparinNasal bleeding and upper gastrointestinal bleeding: 3 case reports
Reactions Weekly, 2023, 1946 (1) : 265 - 265
[29] HeparinHaemothorax, gastrointestinal bleeding and retroperitoneal bleeding: 3 case reports
Reactions Weekly, 2021, 1862 (1) : 226 - 226
[30] RivaroxabanGastrointestinal bleeding: 3 case reports
Reactions Weekly, 2025, 2040 (1) : 878 - 878

← 1 2 3 4 5 →